Drug Shortage Report for BLEPHAMIDE OPHT SUSPENSION

Last updated on 2019-04-19 History
Report ID 77342
Drug Identification Number 00807788
Brand name BLEPHAMIDE OPHT SUSPENSION
Common or Proper name Sulfacetamide-Prednisolone
Company Name ALLERGAN INC
Active Ingredient(s) PREDNISOLONE ACETATE SULFACETAMIDE SODIUM
Strength(s) 0.2% 10%
Dosage form(s) DROPS
Route of administration OPHTHALMIC
Packaging size 10ml
ATC code S01CA
ATC description ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2019-03-04
Actual start date 2019-03-04
Estimated end date 2019-04-16
Actual end date 2019-04-18
Shortage status Resolved
Updated date 2019-04-19
Company comments
Health Canada comments
Company contact information Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2019-04-19 English Compare
v11 2019-04-18 French Compare
v10 2019-04-18 English Compare
v9 2019-04-15 French Compare
v8 2019-04-15 English Compare
v7 2019-04-15 French Compare
v6 2019-04-15 English Compare
v5 2019-04-05 French Compare
v4 2019-04-05 English Compare
v3 2019-03-05 English Compare
v2 2019-03-03 French Compare
v1 2019-03-03 English Compare